Skip to main content
. 2017 Dec 14;2017(12):CD009789. doi: 10.1002/14651858.CD009789.pub2

Shafat 2004.

Methods Randomised controlled trial (parallel design)
Participants Setting: laboratory; Ireland
n = 12 moderately fit, active, non‐smoking men
Mean age vitamin C group 25 (SD 7.5) years
Mean age placebo group 20.6 (SD 1.1) years
Inclusion/exclusion criteria
All volunteers were moderately active non‐smokers who had not participated in any form of resistance training exercise in the previous 6 months. Volunteers who were currently taking supplements in the past 6 months were excluded from the study.
Interventions Intervention
500 mg vitamin C and 1200 IU vitamin E; 2 x 250 mg tablets of vitamin C + 3 tablets 400 IU each vitamin E
Placebo
Glucose
Duration
37 days
Outcomes PRIMARY
Delayed onset muscle soreness was evaluated using a questionnaire employing a visual analogue scale for a total of 8 sites (6 sites on the anterior muscle of the upper leg and 2 sites on the posterior muscles of the upper leg). The participants were asked to palpate the relaxed muscle and rate soreness on a scale of 1 "normal" to 10 "very very sore". Results were summed for the 8 sites so that no soreness is indicated by a score of 8 and maximal muscle soreness by a score of 80.
SECONDARY
Maximal voluntary concentric torque for the knee extensors was measured at an angular velocity of 0.5 rad/s 3 minutes to and 3 minutes following the eccentric contraction bout on the Con‐Trex dynamometer.
Isometric maximum voluntary contraction force (MVC) and electrically simulated force of the knee extensors were measured using a custom made isometric test rig. Volunteers were seated in the upright position with their leg connected to a pre‐calibrated load cell (Novatech, Hastings, UK). Analogue signals from the strain gauge were converted to digital information using an A:D convertor (Powerlab 1400, ADInstruments, Oxfordshire, UK) and were recorded on a PC. The chair was adjusted to allow attachment of the strain gauge above the ankle with the knee at an angle of 1.57 rad (90 degrees). For MVC, volunteers were instructed to contract maximally for 3 seconds and verbally encouraged during their effort. 3 repetitions were performed, separated by 1 minute. The highest peak force value of the 3 repetitions was recorded as the MVC.
Exercise type 30 sets of 10 eccentric knee extensions at a velocity of 0.52 rad·s‐1
Sources of funding None
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk No details in manuscript
Authors were contacted via email on 26 May 2016 and responded on 5 June 2016: "Numbers were drawn out of a hat to determine a set allocation order which was balanced in numbers for treatment and placebo. As participants were recruited to the study, they were allocated to a group according to that random allocation order."
Allocation concealment (selection bias) Unclear risk No details in manuscript
Authors were contacted via email on 26 May 2016 and responded on 5 June 2016: "All volunteers were informed that they were being supplemented. All were supplied with identical labelled dispensers, containing capsules. However, the capsules were not identical in colour or size. We checked, informally, at the end of the testing to see if volunteers thought they were supplemented or controlled and they really had no idea which was which"
Blinding of participants and personnel (performance bias) 
 All outcomes High risk Non‐identical capsules; the personnel were not blinded
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk Non‐identical capsules; some risk of unblinding
Incomplete outcome data (attrition bias) 
 All outcomes Low risk All participants completed the study
Selective reporting (reporting bias) High risk No published protocol available
All outcomes reported at all time points
Adverse effects of antioxidant supplementation were not reported
Other bias Unclear risk Participants that took supplements or smoked were excluded
No details on whether participants were asked to refrain from using anti‐inflammatory drugs or other treatment modalities that could reduce soreness